Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CardioTech gets FDA OK for wound dressing:

This article was originally published in Clinica

Executive Summary

The US FDA has given CardioTech International the green light to sell its new line of wound dressings designed to treat exuding and bleeding wounds. Representing an advanced wound dressing, AlgiMed absorbs wound exude almost instantaneously, and helps control minor bleeding, said the Woburn, Massachusetts firm. Made of calcium alginate, the dressing releases calcium - a potent pro-coagulant - on contact with blood, thus stopping bleeding. CardioTech expects to start selling the product in January 2004. It estimated the advanced wound care market at $1.5bn.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065356

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel